{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T09:06:23Z","timestamp":1794560783568,"version":"4.9.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T00:00:00Z","timestamp":1732579200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFC2508500"],"award-info":[{"award-number":["2023YFC2508500"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002367","name":"Chinese Academy of Sciences","doi-asserted-by":"publisher","award":["XDB36000000"],"award-info":[{"award-number":["XDB36000000"]}],"id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002367","name":"Chinese Academy of Sciences","doi-asserted-by":"publisher","award":["YSBR-041"],"award-info":[{"award-number":["YSBR-041"]}],"id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009592","name":"Beijing Municipal Science and Technology Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009592","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People&apos;s Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005090","name":"Beijing Nova Program","doi-asserted-by":"publisher","award":["202304584382"],"award-info":[{"award-number":["202304584382"]}],"id":[{"id":"10.13039\/501100005090","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32301202"],"award-info":[{"award-number":["32301202"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["T2288102"],"award-info":[{"award-number":["T2288102"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.xcrm.2024.101877","type":"journal-article","created":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T15:33:09Z","timestamp":1734708789000},"page":"101877","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Neoadjuvant chemotherapy by liposomal doxorubicin boosts immune protection of tumor membrane antigens-based nanovaccine"],"prefix":"10.1016","volume":"6","author":[{"given":"Yang","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaohua","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixuan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronghui","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyu","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changhao","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guyu","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanqing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuliang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruifang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5040-9793","authenticated-orcid":false,"given":"Guangjun","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2024.101877_bib1","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nrclinonc.2017.194","article-title":"Perioperative events influence cancer recurrence risk after surgery","volume":"15","author":"Hiller","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.xcrm.2024.101877_bib2","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aar1916","article-title":"Extended release of perioperative immunotherapy prevents tumor recurrence and eliminates metastases","volume":"10","author":"Park","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.xcrm.2024.101877_bib3","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aao5931","article-title":"Personalized cancer vaccine effectively mobilizes antitumor T\u00a0cell immunity in ovarian cancer","volume":"10","author":"Tanyi","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.xcrm.2024.101877_bib4","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1126\/science.aar7112","article-title":"Personalized vaccines for cancer immunotherapy","volume":"359","author":"Sahin","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2024.101877_bib5","article-title":"Metal-Phenolic Nanocloaks on Cancer Cells Potentiate STING Pathway Activation for Synergistic Cancer Immunotherapy","volume":"63","author":"He","year":"2024","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.xcrm.2024.101877_bib6","first-page":"409","article-title":"Autologous tumor vaccine lowering postsurgical recurrent rate of hepatocellular carcinoma","volume":"53","author":"Peng","year":"2006","journal-title":"Hepato-Gastroenterology"},{"key":"10.1016\/j.xcrm.2024.101877_bib7","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1586\/14760584.2014.854169","article-title":"Autologous tumor cell vaccines for post-operative active-specific immunotherapy of colorectal carcinoma: long-term patient survival and mechanism of function","volume":"13","author":"Schirrmacher","year":"2014","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.xcrm.2024.101877_bib8","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aba4024","article-title":"Engineering autologous tumor cell vaccine to locally mobilize antitumor immunity in tumor surgical bed","volume":"6","author":"Fang","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.xcrm.2024.101877_bib9","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.4161\/hv.20740","article-title":"Immunotherapy with autologous tumor cell vaccines for treatment of occult disease in early stage colon cancer","volume":"8","author":"Hanna","year":"2012","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.xcrm.2024.101877_bib10","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jocn.2020.03.006","article-title":"A phase I trial of surgical resection with Gliadel Wafer placement followed by vaccination with dendritic cells pulsed with tumor lysate for patients with malignant glioma","volume":"74","author":"Rudnick","year":"2020","journal-title":"J.\u00a0Clin. Neurosci."},{"key":"10.1016\/j.xcrm.2024.101877_bib11","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1021\/nl500618u","article-title":"Cancer cell membrane-coated nanoparticles for anticancer vaccination and drug delivery","volume":"14","author":"Fang","year":"2014","journal-title":"Nano Lett."},{"key":"10.1016\/j.xcrm.2024.101877_bib12","first-page":"1","article-title":"Proteolytically-cleaved Fragments of Cell-surface Proteins from Live Tumor Cells Stimulate Anti-tumor Immune Response In\u00a0vitro","volume":"01","author":"Balashova","year":"2010","journal-title":"J.\u00a0Carcinog. Mutagen."},{"key":"10.1016\/j.xcrm.2024.101877_bib13","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jconrel.2020.07.008","article-title":"Tumor cell membrane enveloped aluminum phosphate nanoparticles for enhanced cancer vaccination","volume":"326","author":"Gan","year":"2020","journal-title":"J.\u00a0Control. Release"},{"key":"10.1016\/j.xcrm.2024.101877_bib14","first-page":"223","article-title":"Blockading a new NSCLC immunosuppressive target by pluripotent autologous tumor vaccines magnifies sequential immunotherapy","volume":"13","author":"Wu","year":"2022","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.xcrm.2024.101877_bib15","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/s41565-020-00781-4","article-title":"A general strategy towards personalized nanovaccines based on fluoropolymers for post-surgical cancer immunotherapy","volume":"15","author":"Xu","year":"2020","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.xcrm.2024.101877_bib16","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abc2816","article-title":"Bacterial cytoplasmic membranes synergistically enhance the antitumor activity of autologous cancer vaccines","volume":"13","author":"Chen","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.xcrm.2024.101877_bib17","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.medj.2024.03.012","article-title":"Unlocking the power of nanomedicine: Cell membrane-derived biomimetic cancer nanovaccines for cancer treatment","volume":"5","author":"Zhao","year":"2024","journal-title":"Med"},{"key":"10.1016\/j.xcrm.2024.101877_bib18","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1136\/ijgc-2021-002531","article-title":"Neoadjuvant chemotherapy followed by surgery in cervical cancer: past, present and future","volume":"32","author":"Miriyala","year":"2022","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.xcrm.2024.101877_bib19","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1080\/14656566.2020.1746273","article-title":"Neoadjuvant or adjuvant chemotherapy in early breast cancer?","volume":"21","author":"Montemurro","year":"2020","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.xcrm.2024.101877_bib20","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.2147\/DDDT.S253961","article-title":"Evaluation of the Efficacy of Neoadjuvant Chemotherapy for Breast Cancer","volume":"14","author":"Wang","year":"2020","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.xcrm.2024.101877_bib21","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1111\/cas.14398","article-title":"Reprograming the tumor immunologic microenvironment using neoadjuvant chemotherapy in osteosarcoma","volume":"111","author":"Deng","year":"2020","journal-title":"Cancer Sci."},{"key":"10.1016\/j.xcrm.2024.101877_bib22","doi-asserted-by":"crossref","first-page":"5167","DOI":"10.1158\/1078-0432.CCR-22-1125","article-title":"Neoadjuvant Chemotherapy Is Associated with Altered Immune Cell Infiltration and an Anti-Tumorigenic Microenvironment in Resected Pancreatic Cancer","volume":"28","author":"Dias Costa","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2024.101877_bib23","doi-asserted-by":"crossref","first-page":"6483","DOI":"10.1002\/anie.201500934","article-title":"Induction of immunogenic cell death by chemotherapeutic platinum complexes","volume":"54","author":"Wong","year":"2015","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.xcrm.2024.101877_bib24","first-page":"1","article-title":"High-dose chemotherapy: principles, indications and complications","volume":"200","author":"Gobel","year":"1988","journal-title":"Klinische Padiatr"},{"key":"10.1016\/j.xcrm.2024.101877_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1152934","article-title":"Chemotherapeutic and targeted drugs-induced immunogenic cell death in cancer models and antitumor therapy: An update review","volume":"14","author":"Zhai","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.xcrm.2024.101877_bib26","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1093\/annonc\/mdh097","article-title":"Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX\/Doxil) versus conventional doxorubicin for first-line treatment of metastatic breast cancer","volume":"15","author":"O'Brien","year":"2004","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.xcrm.2024.101877_bib27","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1080\/13543776.2020.1825687","article-title":"Small molecule agonists of toll-like receptors 7 and 8: a patent review 2014 - 2020","volume":"30","author":"Kieffer","year":"2020","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.xcrm.2024.101877_bib28","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1016\/j.vaccine.2014.02.027","article-title":"Adjuvant-carrying synthetic vaccine particles augment the immune response to encapsulated antigen and exhibit strong local immune activation without inducing systemic cytokine release","volume":"32","author":"Ilyinskii","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.xcrm.2024.101877_bib29","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.ccell.2019.08.008","article-title":"An Evolutionarily Conserved Function of Polycomb Silences the MHC Class I Antigen Presentation Pathway and Enables Immune Evasion in Cancer","volume":"36","author":"Burr","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2024.101877_bib30","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrc.2016.14","article-title":"Antitumour actions of interferons: implications for cancer therapy","volume":"16","author":"Parker","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.xcrm.2024.101877_bib31","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1158\/2159-8290.CD-20-0812","article-title":"Therapeutically Increasing MHC-I Expression Potentiates Immune Checkpoint Blockade","volume":"11","author":"Gu","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.xcrm.2024.101877_bib32","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/s41568-021-00346-0","article-title":"Therapeutic cancer vaccines","volume":"21","author":"Saxena","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.xcrm.2024.101877_bib33","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3389\/fimmu.2014.00255","article-title":"Dendritic cell-targeted vaccines","volume":"5","author":"Cohn","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2024.101877_bib34","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0014-4800(03)00072-8","article-title":"Function of CD80 and CD86 on monocyte- and stem cell-derived dendritic cells","volume":"75","author":"Dilioglou","year":"2003","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.xcrm.2024.101877_bib35","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/cyto.b.20492","article-title":"Utility of lyophilized PMA and ionomycin to stimulate lymphocytes in whole blood for immunological assays","volume":"78","author":"Belouski","year":"2010","journal-title":"Cytometry B Clin. Cytom."},{"key":"10.1016\/j.xcrm.2024.101877_bib36","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ccr.2013.01.008","article-title":"Role of macrophage targeting in the antitumor activity of trabectedin","volume":"23","author":"Germano","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2024.101877_bib37","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrc.2016.16","article-title":"Vaccines for established cancer: overcoming the challenges posed by immune evasion","volume":"16","author":"van der Burg","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.xcrm.2024.101877_bib38","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.cell.2017.01.017","article-title":"Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy","volume":"168","author":"Sharma","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2024.101877_bib39","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1586\/14760584.2014.969714","article-title":"Current status of autologous breast tumor cell-based vaccines","volume":"13","author":"Kurtz","year":"2014","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.xcrm.2024.101877_bib40","doi-asserted-by":"crossref","first-page":"32","DOI":"10.21037\/cco-20-123","article-title":"Neoadjuvant treatment for HER2-positive breast cancer","volume":"9","author":"Takada","year":"2020","journal-title":"Chin. Clin. Oncol."},{"key":"10.1016\/j.xcrm.2024.101877_bib41","doi-asserted-by":"crossref","first-page":"853","DOI":"10.4103\/0973-1482.139267","article-title":"An overview of doxorubicin formulations in cancer therapy","volume":"10","author":"Rivankar","year":"2014","journal-title":"J.\u00a0Cancer Res. Ther."},{"key":"10.1016\/j.xcrm.2024.101877_bib42","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/CAD.0000000000000182","article-title":"Emerging delivery systems to reduce doxorubicin cardiotoxicity and improve therapeutic index: focus on liposomes","volume":"26","author":"Tahover","year":"2015","journal-title":"Anti Cancer Drugs"},{"key":"10.1016\/j.xcrm.2024.101877_bib43","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/bjs.10471","article-title":"Relationship between tumour size and outcome in pancreatic ductal adenocarcinoma","volume":"104","author":"Ansari","year":"2017","journal-title":"Br. J. Surg."},{"key":"10.1016\/j.xcrm.2024.101877_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.122379","article-title":"A liposomal formulation of simvastatin and doxorubicin for improved cardioprotective and anti-cancer effect","volume":"629","author":"Bjornstad","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.xcrm.2024.101877_bib45","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3892\/ijo.2022.5371","article-title":"The TLR7\/8 agonist R848 optimizes host and tumor immunity to improve therapeutic efficacy in murine lung cancer","volume":"61","author":"Zhou","year":"2022","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.xcrm.2024.101877_bib46","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2021.1907912","article-title":"CD80 expression is upregulated by TP53 activation in human cancer epithelial cells","volume":"10","author":"Scarpa","year":"2021","journal-title":"OncoImmunology"}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379124006487?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379124006487?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,2]],"date-time":"2025-03-02T04:10:27Z","timestamp":1740888627000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379124006487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S2666379124006487"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2024.101877","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neoadjuvant chemotherapy by liposomal doxorubicin boosts immune protection of tumor membrane antigens-based nanovaccine","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2024.101877","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101877"}}